Leon Recanati - 04 Sep 2026 Form 4 Insider Report for Evogene Ltd. (EVGN)

Reporting relationship: Director
Issuer ticker: EVGN
Reported as of: 04 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Sep 2026, 08:13:18 UTC
Prior SEC filing: 23 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Nitsan Deutsch, Attorney-in-fact

Key filing fact

Leon Recanati filed Form 4 for Evogene Ltd. (EVGN) on 30 Sep 2026.

Key facts

This page summarizes Leon Recanati's Form 4 filing for Evogene Ltd. (EVGN).
1 reported transaction and 4 derivative rows are listed below.
Accepted by SEC: 30 Sep 2026, 08:13.

Change

Previous filing in this sequence was filed on 23 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000919590 Primary reporting owner

RECANATI LEON

Relationship: Director
Address: 27 YOAV ST., TEL AVIV, ISRAEL
Signature: /s/ Nitsan Deutsch, Attorney-in-fact
Signature date: 29 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVGN holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,343,886
Date: 04 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +2,500
Change %
Price: $0.000000^*
Shares after: 2,500
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,500
Exercise price: $0.5800
Footnotes: F2, F3, F4

EVGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 250
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 250
Exercise price: $54.32
Footnotes: F1

EVGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,800
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,800
Exercise price: $28.62
Footnotes: F1

EVGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,500
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,500
Exercise price: $1.29
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F2

The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date.

Footnote F3

The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan,

Footnote F4

The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date.

SEC remarks

Exhibit 24.1 - Power of Attorney.